Bill Title: Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical manufacturers.

Spectrum: Partisan Bill (Democrat 2-0)

Status: (Introduced - Dead) 2019-01-17 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee [S3336 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Introduced	2019-01-17	HTML/Text	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for New Jersey S3336

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for New Jersey S3336 currently on file.

Social Comments on NJ S3336